Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

IMPACT 360 for Parkinson's Disease — Stella

Home/Parkinson's Disease (PD)/IMPACT 360 for Parkinson's Disease

View on ClinicalTrials.gov

Recruiting

Back to Parkinson's Disease (PD) trials

IMPACT 360 for Parkinson's Disease

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Canada

University of British Colombia, Vancouver, British Columbia

Key details

Phase

Safety & dosing

Sponsor

University of British Columbia

Enrollment target

~60 participants

Started

October 2024

Primary completion

May 2027

Age range

40 Years – 85 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.